hypercholesterolaemiaevolocumabalirocumabPCSK9iezetimibetertiary care hospitalbempedoic acid
…se subtilisine/kexin 9 inhibitors (PCSK9i) for the treatment of hypercholesterolaemia require long-term monitoring. Close follow-up of these treatmen…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 379 of 2459pneumoniasepsisfluoroquinolonesABUniversity of Debrecen
…d clinical outcomes in patients requiring intensive care due to pneumonia and sepsis.Material and Methods This study was conducted as a s…
Inclisiranhypercholesterolaemiaezetimibetertiary hospitalhypertriglyceridemia
… included (40% women; 60±7 years), all in secondary prevention. Inclisiran was indicated for failure to reach LDL-C targets despite optima…
breast diseaseschest diseaseshaematologychemotherapiesgynaecologycancer centreimmunotherapiestyrosine kinase inhibitorsurologyPaediatrics+1 more
…hers.Most patients were treated in oncology-related committees: breast diseases (387 patients, 2635 preparations), haematology (54, 532), urolo…
96.4%
HIVrilpivirinePLHIVacenocoumarolcabotegravirRPVLong-acting antiretroviral therapy
…ong-acting antiretroviral therapy represents a major advance in HIV management by improving adherence and reducing treatment burden…
InfliximabadalimumabIBDinflammatory bowel disease
…faecal calprotectin (r = –0.10, p = 0.62) were not significant. Infliximab cohort: 145 patients (420 determinations), mean age 47 ± 20 yea…
ceftazidime-avibactam-aztreonamCeftazidimeMBL-producing EnterobacteriaceaeMBL-producing infectionsSepsisaztreonamaztreonam-avibactaminfectionsAvibactam
…CI. Analysis: M365 Copilot.Results Eight-four patients received ceftazidime-avibactam-aztreonam.Abstract 4CPS-113 Table 1Sociodemographic profileMale gender 61…
atogepanttertiary hospitalchronic migraine (CM)CMMMD
…ays). During the study period, 30 patients (55.6%) discontinued atogepant. The mean duration until discontinuation was 2.7±1.7 months. Th…
doxorubicinCyclophosphamideDLBCLrituximabJ Clin OncolR-CHOP/COMPCNS lymphomas
…ed that RDI is a critical determinant of outcome. Higher RDI of doxorubicin (HR 0.75−0.82) and cyclophosphamide (HR 0.97) was significantly…
vancomycinciprofloxacinamikacinamphotericin BCentral venous catheter (CVC)–related infectionsGram-negative infections
…inserted central catheters (PICCs) (4.27%). Lock solutions were vancomycin (74.4%), amikacin (18.8%), ciprofloxacin (3.4%), and liposomal …
pembrolizumabpembrolizumab-chemotherapydoxorubicincarboplatinpaclitaxelcyclophosphamideTriple-negative breast cancer (TNBC)neoadjuvant chemotherapyTNBC
…and poor prognosis. Adding immune checkpoint inhibitors such as pembrolizumab to neoadjuvant chemotherapy has improved pathological response …